Literature DB >> 26173742

Concentration-independent MRI of pH with a dendrimer-based pH-responsive nanoprobe.

Mohammed P I Bhuiyan1, Madhava P Aryal1, Branislava Janic1, Kishor Karki1, Nadimpalli R S Varma1, James R Ewing1, Ali S Arbab2, Meser M Ali1.   

Abstract

The measurement of extracellular pH (pHe ) has significant clinical value for pathological diagnoses and for monitoring the effects of pH-altering therapies. One of the major problems of measuring pHe with a relaxation-based MRI contrast agent is that the longitudinal relaxivity depends on both pH and the concentration of the agent, requiring the use of a second pH-unresponsive agent to measure the concentration. Here we tested the feasibility of measuring pH with a relaxation-based dendritic MRI contrast agent in a concentration-independent manner at clinically relevant field strengths. The transverse and longitudinal relaxation times in solutions of the contrast agent (GdDOTA-4AmP)44 -G5, a G5-PAMAM dendrimer-based MRI contrast agent in water, were measured at 3 T and 7 T magnetic field strengths as a function of pH. At 3 T, longitudinal relaxivity (r1 ) increased from 7.91 to 9.65 mM(-1) s(-1) (on a per Gd(3+) basis) on changing pH from 8.84 to 6.35. At 7 T, r1 relaxivity showed pH response, albeit at lower mean values; transverse relaxivity (r2 ) remained independent of pH and magnetic field strengths. The longitudinal relaxivity of (GdDOTA-4AmP)44 -G5 exhibited a strong and reversible pH dependence. The ratio of relaxation rates R2 /R1 also showed a linear relationship in a pH-responsive manner, and this pH response was independent of the absolute concentration of (GdDOTA-4AmP)44 -G5 agent. Importantly, the nanoprobe (GdDOTA-4AmP)44 -G5 shows pH response in the range commonly found in the microenvironment of solid tumors.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  dendritic agent; magnetic resonance imaging; noninvasive pH measurement; responsive agent

Mesh:

Substances:

Year:  2015        PMID: 26173742      PMCID: PMC4713357          DOI: 10.1002/cmmi.1651

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  50 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na(+)/H(+) exchange, motility, and invasion induced by serum deprivation.

Authors:  S J Reshkin; A Bellizzi; V Albarani; L Guerra; M Tommasino; A Paradiso; V Casavola
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

Review 3.  pH and chemotherapy.

Authors:  N Raghunand; R J Gillies
Journal:  Novartis Found Symp       Date:  2001

4.  Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites.

Authors:  M L García-Martín; G Hérigault; C Rémy; R Farion; P Ballesteros; J A Coles; S Cerdán; A Ziegler
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

5.  Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent.

Authors:  Guanshu Liu; Yuguo Li; Vipul R Sheth; Mark D Pagel
Journal:  Mol Imaging       Date:  2012-02       Impact factor: 4.488

6.  Measuring in vivo tumor pHe with CEST-FISP MRI.

Authors:  Vipul R Sheth; Yuguo Li; Liu Qi Chen; Christine M Howison; Chris A Flask; Mark D Pagel
Journal:  Magn Reson Med       Date:  2011-10-25       Impact factor: 4.668

7.  Experimental metastasis and differentiation of murine melanoma cells: actions and interactions of factors affecting different intracellular signalling pathways.

Authors:  D C Bennett; A Holmes; L Devlin; I R Hart
Journal:  Clin Exp Metastasis       Date:  1994-11       Impact factor: 5.150

8.  A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer.

Authors:  R V Smalley; J Lefante; A Bartolucci; J Carpenter; C Vogel; S Krauss
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

9.  Poly-beta-cyclodextrin based platform for pH mapping via a ratiometric 19F/1H MRI method.

Authors:  Eliana Gianolio; Roberta Napolitano; Franco Fedeli; Francesca Arena; Silvio Aime
Journal:  Chem Commun (Camb)       Date:  2009-09-21       Impact factor: 6.222

10.  Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat glioma.

Authors:  Meser M Ali; Branislava Janic; Abbas Babajani-Feremi; Nadimpalli R S Varma; A S M Iskander; John Anagli; Ali S Arbab
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more
  8 in total

1.  pH-Dependent Cellular Internalization of Paramagnetic Nanoparticle.

Authors:  Branislava Janic; Mohammed Pi Bhuiyan; James R Ewing; Meser M Ali
Journal:  ACS Sens       Date:  2016-08-10       Impact factor: 7.711

2.  Targeting Triple Negative Breast Cancer with a Small-sized Paramagnetic Nanoparticle.

Authors:  Li Zhang; Nadimpalli Rs Varma; Zhang Z Gang; James R Ewing; Ali S Arbab; Meser M Ali
Journal:  J Nanomed Nanotechnol       Date:  2016-10-28

3.  Gear Up for a pH Shift: A Responsive Iron(II) 2-Amino-6-picolyl-Appended Macrocyclic paraCEST Agent That Protonates at a Pendent Group.

Authors:  Pavel B Tsitovich; Jordan M Cox; Joseph A Spernyak; Janet R Morrow
Journal:  Inorg Chem       Date:  2016-11-04       Impact factor: 5.165

Review 4.  Application of Dendrimers in Anticancer Diagnostics and Therapy.

Authors:  Zuzanna Bober; Dorota Bartusik-Aebisher; David Aebisher
Journal:  Molecules       Date:  2022-05-18       Impact factor: 4.927

5.  A DNA-Based MRI Contrast Agent for Quantitative pH Measurement.

Authors:  Hyewon Seo; Kristine Y Ma; Erin E Tuttle; Isen Andrew C Calderon; Alissa D Buskermolen; Chris A Flask; Heather A Clark
Journal:  ACS Sens       Date:  2021-02-24       Impact factor: 9.618

6.  A novel nitroreductase-enhanced MRI contrast agent and its potential application in bacterial imaging.

Authors:  Yun Liu; Leilei Zhang; Marc Nazare; Qingqiang Yao; Hai-Yu Hu
Journal:  Acta Pharm Sin B       Date:  2017-12-06       Impact factor: 11.413

7.  Targeting Glioma with a Dual Mode Optical and Paramagnetic Nanoprobe across the Blood-brain Tumor Barrier.

Authors:  Kishor Karki; James R Ewing; Meser M Ali
Journal:  J Nanomed Nanotechnol       Date:  2016-08-31

8.  Application of Dendrimer-based Nanoparticles in Glioma Imaging.

Authors:  Sunalee Gonawala; Meser M Ali
Journal:  J Nanomed Nanotechnol       Date:  2017-06-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.